|6 Months Ended|
Jun. 30, 2017
|Subsequent Events [Abstract]|
NOTE 15 – SUBSEQUENT EVENTS
On July 11, 2017, pursuant to the June 2017 Offering, see note 7, the Company completed the closing of the sale of 300,000 shares of the Company’s common stock, sold pursuant to the exercise by the Underwriters (defined below) of their remaining over-allotment option, pursuant to the Underwriting Agreement. On June 28, 2017, the Company entered into an underwriting agreement (the “Underwriting Agreement”) with Roth Capital Partners, LLC and Joseph Gunnar & Co., LLC (the “Underwriters”), with respect to the issuance and sale in an underwritten public offering (the “June 2017 Offering”) by the Company of an aggregate of 2,000,000 shares (the “Shares”) of the Company’s common stock, $0.025 par value per share and five year warrants to purchase up to 500,000 shares of Common Stock with an exercise price of $1.90 per Share (the “June 2017 Warrants”), at a combined public offering price of $1.75 per share of Common Stock and quarter-Warrant. Pursuant to the Underwriting Agreement, the Company granted the Underwriters a 45-day option to purchase up to an additional 300,000 shares of Common Stock and/or 75,000 Warrants to purchase shares of Common Stock with an exercise price of $1.90 per share.
The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.
Reference 1: http://www.xbrl.org/2003/role/presentationRef